Victor Appay

University of Bordeaux

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Emmanuel Clave

Université de Paris Faculté de Santé

FRANCE

View details

Kristin Ladell

Clinical Reader & Doctor in Paediatrics

Cardiff University

UNITED KINGDOM

View details

Antonella Caputo

University of Ferrara

ITALY

View details

Francesco Nicoli

University of Ferrara

ITALY

View details

Peter van Endert

Professor of immunology

Université de Paris Faculté de Santé

FRANCE

View details

Livia Pedroza-Martins

Head

FRANCE

View details

delphine sauce

Associate professor

INSERM

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Victor Appay

Research Interests

Explore related searches

Contact this professor

Articles (10)

Les lymphocytes T CD8+ ont-ils une capacité de réplication quasi-illimitée ?

Primary immune responses are negatively impacted by persistent herpesvirus infections in older people: results from an observational study on healthy subjects and a vaccination trial on subjects aged more than 70 years old

Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans

Epitope length variants balance protective immune responses and viral escape in HIV-1 infection.

Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines

A Comparison of Cell Activation, Exhaustion, and Expression of HIV Coreceptors and Restriction Factors in HIV-1- and HIV-2-Infected Nonprogressors

Impaired Priming of SARS-CoV-2-Specific Naive CD8<sup>+</sup> T Cells in Older Subjects.

Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses.

The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8<sup>+</sup> T-cell responses in vitro.

Collaborators (7)

Emmanuel Clave

Kristin Ladell

Antonella Caputo

Francesco Nicoli

Peter van Endert

Livia Pedroza-Martins

delphine sauce

Make your next move.